Abstract: Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
Type:
Grant
Filed:
December 18, 2002
Date of Patent:
August 8, 2006
Assignee:
Bristol-Myers Squibb Company
Inventors:
Mark E. Salvati, James Aaron Balog, Dacia A. Pickering, Hong Zhu